← Back to headlines
Veru Outlines Q1 2027 Interim Readout for Enobosarm Analysis
Veru has provided details on the anticipated Q1 2027 interim readout for its 36-week enobosarm plateau analysis, related to its drug development.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
